Osteosarcoma MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (40 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | |||
{{CMG}}; {{AE}}[[User:DrMars|Mohammadmain Rezazadehsaatlou[2]]]. | |||
{{Osteosarcoma}} | {{Osteosarcoma}} | ||
==Overview== | ==Overview== | ||
On [[Magnetic resonance imaging|MRI]], [[osteosarcoma]] is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on [[T1]]. High signal intensity of soft tissue and low signal intensity of [[ossified]] components on [[MRI|T2]]. Considerable contrast enhancement of solid components on [[T1]] contrast. | |||
==MRI== | ==MRI== | ||
[ | *[[Magnetic resonance imaging|MRI]] is proving essential in accurate local staging and assessment for limb sparing resection, particularly for evaluation of [[intraosseous]] tumor extension and soft-tissue involvement. | ||
<gallery | *Assessment of the [[growth plate]] is also essential as up to 75-88% of [[Metaphyseal dysplasia|metaphyseal tumors]] do cross the [[growth plate]] into the [[epiphysis]]. | ||
*[[Magnetic resonance imaging|MRI]] is used to:<ref name="pmid28808701">{{cite journal |vauthors=Sue M, Oda T, Sasaki Y, Kameta A, Okada Y, Ogura I |title=Osteosarcoma of the Mandible: a Case Report with CT, MRI and Scintigraphy |journal=Chin J Dent Res |volume=20 |issue=3 |pages=169–172 |date=2017 |pmid=28808701 |doi=10.3290/j.cjdr.a38772 |url=}}</ref><ref name="pmid27229874">{{cite journal |vauthors=Kubo T, Furuta T, Johan MP, Adachi N, Ochi M |title=Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis |journal=Skeletal Radiol. |volume=45 |issue=9 |pages=1235–42 |date=September 2016 |pmid=27229874 |doi=10.1007/s00256-016-2410-y |url=}}</ref><ref name="pmid29117758">{{cite journal |vauthors=Kasalak Ö, Overbosch J, Glaudemans AWJM, Boellaard R, Jutte PC, Kwee TC |title=Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET |journal=Acta Oncol |volume=57 |issue=4 |pages=534–540 |date=April 2018 |pmid=29117758 |doi=10.1080/0284186X.2017.1398411 |url=}}</ref><ref name="pmid28806574">{{cite journal |vauthors=Degnan AJ, Chung CY, Shah AJ |title=Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors |journal=Clin Imaging |volume=47 |issue= |pages=9–13 |date=2018 |pmid=28806574 |doi=10.1016/j.clinimag.2017.08.003 |url=}}</ref><ref name="pmid24247589">{{cite journal |vauthors=Uchiyama Y, Matsumoto K, Murakami S, Kanesaki T, Matsumoto A, Kishino M, Furukawa S |title=MRI in a case of osteosarcoma in the temporomandibular joint |journal=Dentomaxillofac Radiol |volume=43 |issue=2 |pages=20130280 |date=2014 |pmid=24247589 |pmc=4064616 |doi=10.1259/dmfr.20130280 |url=}}</ref><ref name="pmid26385785">{{cite journal |vauthors=Wakabayashi H, Saito J, Taki J, Hashimoto N, Tsuchiya H, Gabata T, Kinuya S |title=Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy |journal=Skeletal Radiol. |volume=45 |issue=1 |pages=87–95 |date=January 2016 |pmid=26385785 |doi=10.1007/s00256-015-2250-1 |url=}}</ref> | |||
:*Show how far a bone [[tumor]] has grown inside a bone. | |||
:*Show how much a bone [[tumor]] has grown outside the bone. | |||
:*Observe if a [[tumor]] has grown into [[blood vessels]], [[nerves]], [[bone marrow]] or other nearby tissues or structures. | |||
:*Determine if the tumor has developed in one or more sites within the same bone (skip [[metastases]]). | |||
:*Plan for possible surgery. | |||
On [[Magnetic resonance imaging|MRI]], signal characteristics of [[osteosarcoma]] include: | |||
*'''T1''': | |||
:*Soft tissue, non-mineralized component: intermediate signal intensity. | |||
:*Mineralized/[[ossified]] components: low signal intensity. | |||
:*Peritumoral edema: intermediate signal intensity. | |||
:*Scattered regions of [[hemorrhage]] will have variable signal. | |||
*'''T2''': | |||
:*Soft tissue non-mineralised component: high signal intensity. | |||
:*Mineralised/[[ossified]] components: low signal intensity. | |||
:*peri-tumoral [[edema]]: high signal intensity. | |||
*'''T1 C+ (Gd)''': | |||
:*Solid components show considerable enhancement. | |||
<gallery perrow="3"> | |||
File:Osteosarcoma-distal-femur (1).jpg|Coronal T1 | |||
File:Osteosarcoma-distal-femur (2).jpg|Coronal T1 C+ fat sat | |||
File:Osteosarcoma-distal-femur (3).jpg|Axial T2 | |||
File:Osteosarcoma-distal-femur (4).jpg|Axial T2 fat sat | |||
File:Osteosarcoma-distal-femur (5).jpg|Axial T1 | |||
File:Osteosarcoma-distal-femur (6).jpg|Axial T1 C+ fat sat | |||
</gallery> | </gallery> | ||
*The following table illustrates the findings on MRI for the subtypes of osteosarcoma: | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center" | |||
| valign="top" | | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Subtype}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|MRI findings}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | |||
:Intracortical osteosarcoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*It was believed that intracortical osteosarcoma was confined to the cortex of bone and does not show intramedullary or superficial involvement but it may involve medullary canal as well as surrounding soft tissue. | |||
*It shows peripheral enhancement after intravenous contrast administration. | |||
*T1 - hypointense. | |||
*T2 - intermediate to high signal intensity. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Parosteal osteosarcoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*It exhibits predominantly low signal intensity both on T1 and T2 weighted imaging. High signal intensity on T2 is suggestive of high grade tumor. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Periosteal osteosarcoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Typically hypointense on both T1 and T2 sequences: may see bony spicules radiating from surface lesion (sunburst pattern). | |||
*It may appear hyperintense on T2 sequence which represents its chondroid matrix. | |||
*Reactive marrow changes are commonly observed, but true marrow invasion is rare. | |||
*It is difficult to differentiate periosteal osteosarcoma from the conventional high grade osteosarcoma at imaging, however conventional osteosarcomas involve entire circumference of cortex and show intramedullary extension. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Telangiectatic osteosarcoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Commonly shows fluid-fluid levels within the lesion (~90% of cases) with variable signal intensity. | |||
*Allows appreciation of surrounding soft tissue components. | |||
*Signal characteristics are often heterogeneous. | |||
*Enhancement of septations as well as the soft tissue component may be observed. | |||
*Hemorrhage appears as hyperintense on T1 and variable signal intensity on T2. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Extra skeletal osteosarcoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Well circumscribed heterogeneous mass lesion with presence of haemorrhage and necrotic areas. | |||
*T1: isointense to muscles. | |||
*T2: hyperintense. | |||
*Hyperintense foci on both T1 and T2 sequences (due to methaemoglobin) or hypointense foci on T2 (due to haemosiderin). | |||
*In extreme cases of hemorrhage it can mimic [[hematoma]]. | |||
|- | |||
|} | |||
==References== | ==References== | ||
| Line 25: | Line 100: | ||
[[Category:Orthopedics]] | [[Category:Orthopedics]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Orthopedics]] | |||
Latest revision as of 13:33, 17 October 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].
|
Osteosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteosarcoma MRI On the Web |
|
American Roentgen Ray Society Images of Osteosarcoma MRI |
Overview
On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on T1. High signal intensity of soft tissue and low signal intensity of ossified components on T2. Considerable contrast enhancement of solid components on T1 contrast.
MRI
- MRI is proving essential in accurate local staging and assessment for limb sparing resection, particularly for evaluation of intraosseous tumor extension and soft-tissue involvement.
- Assessment of the growth plate is also essential as up to 75-88% of metaphyseal tumors do cross the growth plate into the epiphysis.
- MRI is used to:[1][2][3][4][5][6]
- Show how far a bone tumor has grown inside a bone.
- Show how much a bone tumor has grown outside the bone.
- Observe if a tumor has grown into blood vessels, nerves, bone marrow or other nearby tissues or structures.
- Determine if the tumor has developed in one or more sites within the same bone (skip metastases).
- Plan for possible surgery.
On MRI, signal characteristics of osteosarcoma include:
- T1:
- Soft tissue, non-mineralized component: intermediate signal intensity.
- Mineralized/ossified components: low signal intensity.
- Peritumoral edema: intermediate signal intensity.
- Scattered regions of hemorrhage will have variable signal.
- T2:
- T1 C+ (Gd):
- Solid components show considerable enhancement.
-
Coronal T1 -
Coronal T1 C+ fat sat -
Axial T2 -
Axial T2 fat sat -
Axial T1 -
Axial T1 C+ fat sat
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
- The following table illustrates the findings on MRI for the subtypes of osteosarcoma:
| Subtype | MRI findings |
|---|---|
|
|
|
|
|
|
|
|
|
|
References
- ↑ Sue M, Oda T, Sasaki Y, Kameta A, Okada Y, Ogura I (2017). "Osteosarcoma of the Mandible: a Case Report with CT, MRI and Scintigraphy". Chin J Dent Res. 20 (3): 169–172. doi:10.3290/j.cjdr.a38772. PMID 28808701.
- ↑ Kubo T, Furuta T, Johan MP, Adachi N, Ochi M (September 2016). "Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis". Skeletal Radiol. 45 (9): 1235–42. doi:10.1007/s00256-016-2410-y. PMID 27229874.
- ↑ Kasalak Ö, Overbosch J, Glaudemans A, Boellaard R, Jutte PC, Kwee TC (April 2018). "Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET". Acta Oncol. 57 (4): 534–540. doi:10.1080/0284186X.2017.1398411. PMID 29117758. Vancouver style error: initials (help)
- ↑ Degnan AJ, Chung CY, Shah AJ (2018). "Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors". Clin Imaging. 47: 9–13. doi:10.1016/j.clinimag.2017.08.003. PMID 28806574.
- ↑ Uchiyama Y, Matsumoto K, Murakami S, Kanesaki T, Matsumoto A, Kishino M, Furukawa S (2014). "MRI in a case of osteosarcoma in the temporomandibular joint". Dentomaxillofac Radiol. 43 (2): 20130280. doi:10.1259/dmfr.20130280. PMC 4064616. PMID 24247589.
- ↑ Wakabayashi H, Saito J, Taki J, Hashimoto N, Tsuchiya H, Gabata T, Kinuya S (January 2016). "Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy". Skeletal Radiol. 45 (1): 87–95. doi:10.1007/s00256-015-2250-1. PMID 26385785.